Corlanor and Flexeril drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Corlanor (ivabradine hydrochloride) and Flexeril (cyclobenzaprine hydrochloride). Common drug interactions include pain among females and central nervous system lesion among males.
The phase IV clinical study analyzes what interactions people have when they take Corlanor and Flexeril. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Corlanor?
Corlanor has active ingredients of ivabradine hydrochloride. eHealthMe is studying from 2,453 Corlanor users. Check the latest studies of Corlanor.
What is Flexeril?
Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.
18 people who take Corlanor and Flexeril together, and have interactions are studied.

What are the common drug interactions of Corlanor and Flexeril, by gender? *:
female:
- Pain
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Cough
- Exostosis (formation of new bone on the surface of a bone)
- Hyperkeratosis (thickening of the outer layer of the skin)
- Hypersensitivity
- Injection site bruising
- Injection site pain
- Injection site rash
- Pain in extremity
male:
- Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
- Cerebellar infarction (impaired blood circulation to cerebellum)
- Nephrolithiasis (calculi in the kidneys)
- Night sweats (sweating in night)
- Protein s deficiency
- Pyrexia (fever)
- Thrombocytopenia (decrease of platelets in blood)
- Thrombocytosis
- Type 2 diabetes mellitus
- Vision blurred
What are the common drug interactions of Corlanor and Flexeril, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Agitation (state of anxiety or nervous excitement)
- Akathisia (a movement disorder characterized by a feeling of inner restlessness)
- Inflammatory marker increased
- Injection site bruising
- Injection site pain
- Injection site ulcer
- Upper respiratory tract infection
30-39:
n/a
40-49:
- Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
- Dry skin
- Dyspnoea (difficult or laboured respiration)
- Erythema (redness of the skin)
- Fatigue (feeling of tiredness)
- Heart rate increased
- Nausea (feeling of having an urge to vomit)
- Pruritus (severe itching of the skin)
- Sleep disorder
- Visual impairment
50-59:
- Dyspnoea (difficult or laboured respiration)
- Folate deficiency (lack of folic acid)
- Headache (pain in head)
- Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
- Meningitis viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
- Nephrolithiasis (calculi in the kidneys)
- Night sweats (sweating in night)
- Protein s deficiency
- Pyrexia (fever)
- Thrombocytopenia (decrease of platelets in blood)
60+:
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Fall
- Psychotic disorder
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
What are the existing conditions these people have? *
- Hypersensitivity: 3 people, 16.67%
- Nausea (feeling of having an urge to vomit): 3 people, 16.67%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 16.67%
- Pain: 3 people, 16.67%
- Asthma: 2 people, 11.11%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 11.11%
- Stress And Anxiety: 2 people, 11.11%
- Muscle Disorder (muscle disease): 2 people, 11.11%
- Arrhythmias (irregular heartbeat): 2 people, 11.11%
- Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 2 people, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Corlanor and Flexeril?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Corlanor and Flexeril:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Corlanor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Flexeril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Corlanor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Flexeril and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ivabradine hydrochloride and cyclobenzaprine hydrochloride (the active ingredients of Corlanor and Flexeril, respectively), and Corlanor and Flexeril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Tamiflu and Vyvanse - 5 seconds ago
- Could Carbamazepine cause Hypocalcaemia? - 6 seconds ago
- Blood Magnesium Decreased and Blood Glucose Decreased - 10 seconds ago
- Inspra vs. Pradaxa, side effect and effectiveness comparison - 13 seconds ago
- Could Diclofenac Sodium cause Macular Degeneration? - 13 seconds ago
- Could Tylenol W/ Codeine cause Disability? - 37 seconds ago
- Drug interactions of Tramadol and Rifaximin - 38 seconds ago
- Rasilez vs. Hydralazine And Hydrochlorthiazide, side effect and effectiveness comparison - 57 seconds ago
- Could Ambien cause White Blood Cell Count Increased? - a minute ago
- Could Linagliptin cause Renal Tubular Acidosis? - a minute ago